China Medical System Stock Operating Margin
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
China Medical System fundamentals help investors to digest information that contributes to China Medical's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Medical pink sheet.
China |
China Medical System Company Operating Margin Analysis
China Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current China Medical Operating Margin | 0.37 % |
Most of China Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medical System is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, China Medical System has an Operating Margin of 0.3735%. This is 101.06% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 106.78% lower than that of the firm.
China Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medical could also be used in its relative valuation, which is a method of valuing China Medical by comparing valuation metrics of similar companies.China Medical is currently under evaluation in operating margin category among its peers.
China Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 8.34 B | |||
| Gross Profit | 6.25 B | |||
| EBITDA | 3.48 B | |||
| Net Income | 3.02 B | |||
| Cash And Equivalents | 5.25 B | |||
| Cash Per Share | 2.14 X | |||
| Total Debt | 573.81 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 3.16 X | |||
| Book Value Per Share | 5.64 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 0.19 X | |||
| Number Of Employees | 5.45 K | |||
| Beta | 0.82 | |||
| Market Capitalization | 4.19 B | |||
| Total Asset | 15.81 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 15.81 B | |||
| Last Dividend Paid | 0.52 |
About China Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medical System's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medical System based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |